Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nitroprusside in decompensated heart failure: what should a clinician really know?

Literature DB >> 19723460

Nitroprusside in decompensated heart failure: what should a clinician really know?

Cristina Opasich¹, Giovanni Cioffi, Alessandra Gualco.

Abstract

Sodium nitroprusside is an older intravenous vasodilator appropriate for acute hospital treatment of patients with congestive heart failure. It is a balanced arterial and venous vasodilator with a very short half-life, facilitating rapid titration. In general, it improves hemodynamic and clinical status by reducing systemic vascular resistance, left ventricular filling pressure, and increasing cardiac output. This review summarizes recently published literature and recent data regarding the use of this intravenous vasodilator in decompensated heart failure patients.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2009 PMID： 19723460 DOI： 10.1007/s11897-009-0026-4

Source DB: PubMed Journal: Curr Heart Fail Rep ISSN： 1546-9530

47 in total

1. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure.

Authors: Wendy Johnson; Torbjørn Omland; Christian Hall; Caroline Lucas; Ole L Myking; Caroline Collins; Marc Pfeffer; Jean-Lucien Rouleau; Lynne W Stevenson
Journal: J Am Coll Cardiol Date: 2002-05-15 Impact factor: 24.094

2. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.

Authors: Giovanni Cioffi; Luigi Tarantini; Carlo Stefenelli; Giordano Azzetti; Russo Marco; Sergio Carlucci; Francesco Furlanello
Journal: J Card Fail Date: 2006-10 Impact factor: 5.712

3. Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome.

Authors: S Capomolla; O Febo; C Opasich; G Guazzotti; A Caporotondi; M T La Rovere; M Gnemmi; A Mortara; M Vona; G D Pinna; R Maestri; F Cobelli
Journal: Eur J Heart Fail Date: 2001-10 Impact factor: 15.534

4. Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy.

Authors: L W Stevenson; J H Tillisch; M Hamilton; M Luu; C Chelimsky-Fallick; J Moriguchi; J Kobashigawa; J Walden
Journal: Am J Cardiol Date: 1990-12-01 Impact factor: 2.778

5. Acute reduction of atrial overload during vasodilator and diuretic therapy in advanced congestive heart failure.

Authors: M A Hamilton; L W Stevenson; J S Child; J D Moriguchi; M Woo
Journal: Am J Cardiol Date: 1990-05-15 Impact factor: 2.778

Review 6. Vasodilators in the management of acute heart failure.

Authors: Uri Elkayam; Munir Janmohamed; Munira Habib; Parta Hatamizadeh
Journal: Crit Care Med Date: 2008-01 Impact factor: 7.598

7. Nitroprusside.

Authors: J N Cohn; L P Burke
Journal: Ann Intern Med Date: 1979-11 Impact factor: 25.391

8. Sodium nitroprusside for advanced low-output heart failure.

Authors: Wilfried Mullens; Zuheir Abrahams; Gary S Francis; Hadi N Skouri; Randall C Starling; James B Young; David O Taylor; W H Wilson Tang
Journal: J Am Coll Cardiol Date: 2008-07-15 Impact factor: 24.094

9. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.

Authors: Maria Rosa Costanzo; R S Johannes; Michael Pine; Vikas Gupta; Mitchell Saltzberg; Joel Hay; Clyde W Yancy; Gregg C Fonarow
Journal: Am Heart J Date: 2007-08 Impact factor: 4.749

10. Prevalence, predictors and prognostic value of acute impairment in renal function during intensive unloading therapy in a community population hospitalized for decompensated heart failure.

Authors: Giovanni Cioffi; Luigi Tarantini; Giovanni Pulignano; Donatella Del Sindaco; Stefania De Feo; Cristina Opasich; Andrea Dilenarda; Carlo Stefenelli; Francesco Furlanello
Journal: J Cardiovasc Med (Hagerstown) Date: 2007-06 Impact factor: 2.160

4 in total

Review 4. Nitric oxide (NO) and nanoparticles - Potential small tools for the war against COVID-19 and other human coronavirus infections.

Authors: Joana C Pieretti; Olga Rubilar; Richard B Weller; Gonzalo R Tortella; Amedea B Seabra
Journal: Virus Res Date: 2020-10-18 Impact factor: 3.303